Chemical Structure : AZD-7624
CAS No.: 1095004-78-6
Catalog No.: PC-63284Not For Human Use, Lab Use Only.
AZD-7624 (AZD7624) is a potent, selective, inhaled p38α MAPK inhibitor with pIC50 of 10.0, displays 15-fold selectivity for p38α over p38β MAPK and >10,000-fold selectivity over p38γ and p38δ MAPK.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $188 | In stock | |
10 mg | $298 | In stock | |
25 mg | $468 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AZD-7624 (AZD7624) is a potent, selective, inhaled p38α MAPK inhibitor with pIC50 of 10.0, displays 15-fold selectivity for p38α over p38β MAPK and >10,000-fold selectivity over p38γ and p38δ MAPK.
AZD-7624 inhibits LPS-induced TNF-α and IL-6 release in human alveolar macrophages pIC50 of 9.2 and 8.8, respectively。
AZD-7624 shows potential for prevention of exacerbations in COPD.
M.Wt | 491.56 | |
Formula | C27H30FN5O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-cyclopropyl-3-fluoro-4-methyl-5-(3-((1-(2-(2-(methylamino)ethoxy)phenyl)cyclopropyl)amino)-2-oxopyrazin-1(2H)-yl)benzamide |
1. Patel NR, et al. Int J Chron Obstruct Pulmon Dis. 2018 Mar 27;13:1009-1019.
2. Pehrson R, et al. J Pharmacol Exp Ther. 2018 Mar 16. pii: jpet.117.246132.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright